← Leaderboards
Livia Schiavinato Eberlin
Stanford University
$7,115,391
Attributed
$11,782,330
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,782,330 · 11
By mechanism
R01$6,765,432 · 4
S10$1,463,627 · 1
R33$1,283,354 · 1
R00$676,560 · 1
UH3$637,011 · 1
R21$453,781 · 1
Top collaborators
- Parag Kumar Mallick6 shared
- Merina Thekenangarpadiyil Varghese6 shared
- Rongrong Huang4 shared
- James Suliburk4 shared
- Bryan Michael Burt3 shared
- Justin Wiseman3 shared
- Amir A Jazaeri1 shared
- Anil K Sood1 shared
Most similar at Stanford University
Same institution · by research overlap
- Linda C Giudice$28,525,430
- Michelle Louise James$4,919,512
- Quynh-Thu X Le$15,492,013
- Atul J Butte$18,222,490
- Stacy L McAllister$1,806,105
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTissuesDetectionMass Spectrum AnalysisTechnologyMetabolicValidationInnovationOperative Surgical ProceduresProceduresDiagnosisSpecimenSamplingMolecular ProfilingPerformanceExcisionPatient CareIn SituPathologicProspectiveSpecificityNew TechnologyMass Spectrometric ImagingMedicine
Grant awards (29)
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$807,254
R01 · FY2025 · AG
Development of the MasSpec Pen Technology to Guide Surgical Decisions in the Care for Patients with Ovarian Cancer$697,317
R01 · FY2025 · CA · contact PI
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer$603,561
R01 · FY2025 · CA · contact PI
Clinical Validation of Metabolic Markers Detected by Mass Spectrometry Imaging for Diagnosis of Thyroid Fine Needle Aspiration Biopsies$317,805
UH3 · FY2025 · CA
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$94,829
R01 · FY2025 · AG
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$819,435
R01 · FY2024 · AG
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer$557,296
R01 · FY2024 · CA · contact PI
Clinical Validation of Metabolic Markers Detected by Mass Spectrometry Imaging for Diagnosis of Thyroid Fine Needle Aspiration Biopsies$319,206
UH3 · FY2024 · CA
Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies$175,444
R01 · FY2024 · HD · contact PI
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$71,342
R01 · FY2024 · AG
Bruker timsTOF fleX MALDI-2 LC MS System$1,463,627
S10 · FY2023 · OD · contact PI
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$860,474
R01 · FY2023 · AG
Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer$601,550
R01 · FY2023 · CA · contact PI
Clinical Validation of Metabolic Markers Detected by Mass Spectrometry Imaging for Diagnosis of Thyroid Fine Needle Aspiration Biopsies$182,874
UH2 · FY2023 · CA
Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies$177,216
R01 · FY2023 · HD · contact PI
Mass spectrometry and multiplexed immunofluorescence imaging of metabolic and proteomic contributors to selective neuronal vulnerability in Alzheimer's disease$880,858
R01 · FY2022 · AG
Development of the MasSpec Pen Technology for Rapid and Accurate Identification of Pediatric Infections$194,988
R21 · FY2022 · HD · contact PI
Clinical Validation of Metabolic Markers Detected by Mass Spectrometry Imaging for Diagnosis of Thyroid Fine Needle Aspiration Biopsies$186,608
UH2 · FY2022 · CA
Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies$184,635
R01 · FY2022 · HD · contact PI
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation$485,413
R33 · FY2021 · CA · contact PI
Development of the MasSpec Pen Technology for Rapid and Accurate Identification of Pediatric Infections$258,793
R21 · FY2021 · HD · contact PI
Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies$234,220
R01 · FY2021 · HD · contact PI
Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies$1
R01 · FY2021 · HD · contact PI
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation$386,000
R33 · FY2020 · CA · contact PI
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation$411,941
R33 · FY2019 · CA · contact PI
Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers$235,946
R00 · FY2018 · CA · contact PI
Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers$191,648
R00 · FY2017 · CA · contact PI
Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers$248,966
R00 · FY2016 · CA · contact PI
Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers$133,083
K99 · FY2015 · CA · contact PI